The Orphan Drugs market was valued at USD 174.11 Billion in 2022 and is expected to reach USD 359.86 Billion by 2030, growing at a CAGR of 9.5% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.